Noreen Henig

Noreen Henig

Director/Board Member at
Lazard Healthcare Acquisition Corp. I
61 year
Health Technology
Consumer Services
Commercial Services

Profile

Noreen Roth Henig is currently an Independent Director at Lazard Healthcare Acquisition Corp.
I.
Former positions include Independent Director at Avidity Biosciences, Inc. (2019–2026), Independent Director at Lazard Growth Acquisition Corp.
I (2021–2023), Chief Medical Officer at Kezar Life Sciences, Inc. (2020–2023), Chief Medical Officer at Breath Therapeutics GmbH (2018–2020), Chief Development Officer at ProQR Therapeutics NV (2014–2017), Senior Director-Global Respiratory at Gilead Sciences, Inc. (2011–2014), and Director-Adult Cystic Fibrosis Care Centers at Cystic Fibrosis Foundation (1999–2008).
Education includes an undergraduate degree from Yale University (1987) and a doctorate from Albert Einstein College of Medicine, Inc. (1991).

Noreen Henig active positions

CompaniesPositionStart
Director/Board Member -

Former positions of Noreen Henig

CompaniesPositionEnd
AVIDITY BIOSCIENCES, INC. Director/Board Member 27/02/2026
KEZAR LIFE SCIENCES, INC. Chief Tech/Sci/R&D Officer 06/10/2023
LAZARD GROWTH ACQUISITION CORP. I Director/Board Member 01/02/2023
Chief Tech/Sci/R&D Officer 01/03/2020
PROQR THERAPEUTICS N.V. Corporate Officer/Principal 01/11/2017
See the detail of Noreen Henig's experience

Training of Noreen Henig

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

81

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Consumer Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Electronic Technology

Finance